About this data
What it is
An investor who owns more than 5% of a public company must say so. Investors who may try to influence the company, such as activists, file the longer Schedule 13D; passive holders file the shorter Schedule 13G.
Who files it
The investor, within days of crossing 5%, and again whenever the stake changes materially.
How current
We collect new filings throughout the day on SEC business days.
Worth knowing
13G filings are far more common than 13D. A 13D usually means the investor intends to push for changes, so it tends to get more attention.

All of this comes from public filings.

Filings per day, last 30 days

0200400600800Oct 17 · 13D (activist): 0Oct 17 · 13G (passive): 0Oct 17Oct 18 · 13D (activist): 0Oct 18 · 13G (passive): 0Oct 19 · 13D (activist): 13Oct 19 · 13G (passive): 75Oct 20 · 13D (activist): 16Oct 20 · 13G (passive): 34Oct 21 · 13D (activist): 11Oct 21 · 13G (passive): 31Oct 21Oct 22 · 13D (activist): 16Oct 22 · 13G (passive): 48Oct 23 · 13D (activist): 13Oct 23 · 13G (passive): 24Oct 24 · 13D (activist): 0Oct 24 · 13G (passive): 0Oct 25 · 13D (activist): 0Oct 25 · 13G (passive): 0Oct 25Oct 26 · 13D (activist): 19Oct 26 · 13G (passive): 25Oct 27 · 13D (activist): 16Oct 27 · 13G (passive): 380Oct 28 · 13D (activist): 22Oct 28 · 13G (passive): 60Oct 29 · 13D (activist): 16Oct 29 · 13G (passive): 47Oct 29Oct 30 · 13D (activist): 16Oct 30 · 13G (passive): 343Oct 31 · 13D (activist): 0Oct 31 · 13G (passive): 0Nov 1 · 13D (activist): 0Nov 1 · 13G (passive): 0Nov 2 · 13D (activist): 20Nov 2 · 13G (passive): 36Nov 2Nov 3 · 13D (activist): 22Nov 3 · 13G (passive): 45Nov 4 · 13D (activist): 19Nov 4 · 13G (passive): 67Nov 5 · 13D (activist): 15Nov 5 · 13G (passive): 311Nov 6 · 13D (activist): 40Nov 6 · 13G (passive): 191Nov 6Nov 7 · 13D (activist): 0Nov 7 · 13G (passive): 0Nov 8 · 13D (activist): 0Nov 8 · 13G (passive): 0Nov 9 · 13D (activist): 40Nov 9 · 13G (passive): 140Nov 10 · 13D (activist): 27Nov 10 · 13G (passive): 289Nov 10Nov 11 · 13D (activist): 0Nov 11 · 13G (passive): 0Nov 12 · 13D (activist): 34Nov 12 · 13G (passive): 277Nov 13 · 13D (activist): 26Nov 13 · 13G (passive): 690Nov 14 · 13D (activist): 0Nov 14 · 13G (passive): 0Nov 14Nov 15 · 13D (activist): 0Nov 15 · 13G (passive): 0
0200400600800Oct 17 · 13D (activist): 0Oct 17 · 13G (passive): 0Oct 17Oct 18 · 13D (activist): 0Oct 18 · 13G (passive): 0Oct 19 · 13D (activist): 13Oct 19 · 13G (passive): 75Oct 20 · 13D (activist): 16Oct 20 · 13G (passive): 34Oct 21 · 13D (activist): 11Oct 21 · 13G (passive): 31Oct 21Oct 22 · 13D (activist): 16Oct 22 · 13G (passive): 48Oct 23 · 13D (activist): 13Oct 23 · 13G (passive): 24Oct 24 · 13D (activist): 0Oct 24 · 13G (passive): 0Oct 25 · 13D (activist): 0Oct 25 · 13G (passive): 0Oct 25Oct 26 · 13D (activist): 19Oct 26 · 13G (passive): 25Oct 27 · 13D (activist): 16Oct 27 · 13G (passive): 380Oct 28 · 13D (activist): 22Oct 28 · 13G (passive): 60Oct 29 · 13D (activist): 16Oct 29 · 13G (passive): 47Oct 29Oct 30 · 13D (activist): 16Oct 30 · 13G (passive): 343Oct 31 · 13D (activist): 0Oct 31 · 13G (passive): 0Nov 1 · 13D (activist): 0Nov 1 · 13G (passive): 0Nov 2 · 13D (activist): 20Nov 2 · 13G (passive): 36Nov 2Nov 3 · 13D (activist): 22Nov 3 · 13G (passive): 45Nov 4 · 13D (activist): 19Nov 4 · 13G (passive): 67Nov 5 · 13D (activist): 15Nov 5 · 13G (passive): 311Nov 6 · 13D (activist): 40Nov 6 · 13G (passive): 191Nov 6Nov 7 · 13D (activist): 0Nov 7 · 13G (passive): 0Nov 8 · 13D (activist): 0Nov 8 · 13G (passive): 0Nov 9 · 13D (activist): 40Nov 9 · 13G (passive): 140Nov 10 · 13D (activist): 27Nov 10 · 13G (passive): 289Nov 10Nov 11 · 13D (activist): 0Nov 11 · 13G (passive): 0Nov 12 · 13D (activist): 34Nov 12 · 13G (passive): 277Nov 13 · 13D (activist): 26Nov 13 · 13G (passive): 690Nov 14 · 13D (activist): 0Nov 14 · 13G (passive): 0Nov 14Nov 15 · 13D (activist): 0Nov 15 · 13G (passive): 0

13D (activist) 13G (passive)

Latest ownership filings

Reset

Showing: ticker ACET

Latest ownership filings
FiledScheduleBoth report a stake of more than 5%. A 13D is filed by investors who may try to influence the company, such as activists; a 13G by passive holders.CompanyInvestorShares% of sharesFiling
Oct 28, 2026SCHEDULE 13G/A (amended)ACET
Adicet Bio, Inc.
Franklin Advisers, Inc.724,1387.7%SCHEDULE 13G/A ↗
Oct 28, 2026SCHEDULE 13G/A (amended)ACET
Adicet Bio, Inc.
Rupert H. Johnson, Jr.00.0%SCHEDULE 13G/A ↗
Oct 28, 2026SCHEDULE 13G/A (amended)ACET
Adicet Bio, Inc.
Charles B. Johnson00.0%SCHEDULE 13G/A ↗
Oct 28, 2026SCHEDULE 13G/A (amended)ACET
Adicet Bio, Inc.
Franklin Templeton, Inc.724,1387.7%SCHEDULE 13G/A ↗
Oct 23, 2026SCHEDULE 13GACET
Adicet Bio, Inc.
Lauren Marie Zedek502,3095.4%SCHEDULE 13G ↗
Oct 23, 2026SCHEDULE 13GACET
Adicet Bio, Inc.
Zedek Daniel Clayton502,3095.4%SCHEDULE 13G ↗
Aug 14, 2026SCHEDULE 13G/A (amended)ACET
Adicet Bio, Inc.
RA Capital Healthcare Fund, L.P.935,4869.9%SCHEDULE 13G/A ↗
Aug 14, 2026SCHEDULE 13G/A (amended)ACET
Adicet Bio, Inc.
Rajeev Shah935,4869.9%SCHEDULE 13G/A ↗
Aug 14, 2026SCHEDULE 13G/A (amended)ACET
Adicet Bio, Inc.
Peter Kolchinsky935,4869.9%SCHEDULE 13G/A ↗
Aug 14, 2026SCHEDULE 13G/A (amended)ACET
Adicet Bio, Inc.
RA Capital Management, L.P.935,4869.9%SCHEDULE 13G/A ↗
May 15, 2026SCHEDULE 13G/A (amended)ACET
Adicet Bio, Inc.
Woodline Partners LP313,1243.3%SCHEDULE 13G/A ↗
Apr 13, 2026SCHEDULE 13G/A (amended)ACET
Adicet Bio, Inc.
RA Capital Healthcare Fund, L.P.1.18M12.3%SCHEDULE 13G/A ↗
Apr 13, 2026SCHEDULE 13G/A (amended)ACET
Adicet Bio, Inc.
Rajeev Shah1.18M12.3%SCHEDULE 13G/A ↗
Apr 13, 2026SCHEDULE 13G/A (amended)ACET
Adicet Bio, Inc.
Peter Kolchinsky1.18M12.3%SCHEDULE 13G/A ↗
Apr 13, 2026SCHEDULE 13G/A (amended)ACET
Adicet Bio, Inc.
RA Capital Management, L.P.1.18M12.3%SCHEDULE 13G/A ↗
Apr 10, 2026SCHEDULE 13D/A (amended)ACET
Adicet Bio, Inc.
Orbimed Israel Biofund GP Limited Partnership00.0%SCHEDULE 13D/A ↗
Apr 10, 2026SCHEDULE 13D/A (amended)ACET
Adicet Bio, Inc.
Orbimed Israel GP Ltd.00.0%SCHEDULE 13D/A ↗
Apr 10, 2026SCHEDULE 13D/A (amended)ACET
Adicet Bio, Inc.
Orbimed Israel GP II, L.P.00.0%SCHEDULE 13D/A ↗
Apr 10, 2026SCHEDULE 13D/A (amended)ACET
Adicet Bio, Inc.
Orbimed Advisors Israel II Ltd00.0%SCHEDULE 13D/A ↗
Apr 10, 2026SCHEDULE 13D/A (amended)ACET
Adicet Bio, Inc.
OrbiMed Genesis GP LLC00.0%SCHEDULE 13D/A ↗
Apr 10, 2026SCHEDULE 13D/A (amended)ACET
Adicet Bio, Inc.
Orbimed Capital GP V LLC564,1475.9%SCHEDULE 13D/A ↗
Apr 10, 2026SCHEDULE 13D/A (amended)ACET
Adicet Bio, Inc.
Orbimed Capital GP VI LLC280,6402.9%SCHEDULE 13D/A ↗
Apr 10, 2026SCHEDULE 13D/A (amended)ACET
Adicet Bio, Inc.
Orbimed Advisors LLC844,7878.8%SCHEDULE 13D/A ↗
Feb 17, 2026SCHEDULE 13G/A (amended)ACET
Adicet Bio, Inc.
RA Capital Healthcare Fund, L.P.960,2379.9%SCHEDULE 13G/A ↗
Feb 17, 2026SCHEDULE 13G/A (amended)ACET
Adicet Bio, Inc.
Rajeev Shah960,2379.9%SCHEDULE 13G/A ↗
Feb 17, 2026SCHEDULE 13G/A (amended)ACET
Adicet Bio, Inc.
Peter Kolchinsky960,2379.9%SCHEDULE 13G/A ↗
Feb 17, 2026SCHEDULE 13G/A (amended)ACET
Adicet Bio, Inc.
RA Capital Management, L.P.960,2379.9%SCHEDULE 13G/A ↗
Feb 17, 2026SCHEDULE 13G/A (amended)ACET
Adicet Bio, Inc.
Tang Capital Partners IV, Inc00.0%SCHEDULE 13G/A ↗
Feb 17, 2026SCHEDULE 13G/A (amended)ACET
Adicet Bio, Inc.
Tang Capital Partners III, Inc00.0%SCHEDULE 13G/A ↗
Feb 17, 2026SCHEDULE 13G/A (amended)ACET
Adicet Bio, Inc.
Tang Capital Partners International, LP6,1580.1%SCHEDULE 13G/A ↗
Feb 17, 2026SCHEDULE 13G/A (amended)ACET
Adicet Bio, Inc.
Tang Capital Partners, LP00.0%SCHEDULE 13G/A ↗
Feb 17, 2026SCHEDULE 13G/A (amended)ACET
Adicet Bio, Inc.
Kevin Tang6,1580.1%SCHEDULE 13G/A ↗
Feb 17, 2026SCHEDULE 13G/A (amended)ACET
Adicet Bio, Inc.
Tang Capital Management, LLC6,1580.1%SCHEDULE 13G/A ↗
Feb 17, 2026SCHEDULE 13GACET
Adicet Bio, Inc.
Woodline Partners LP625,0006.5%SCHEDULE 13G ↗
Jan 29, 2026SCHEDULE 13GACET
Adicet Bio, Inc.
Franklin Advisers, Inc.626,5716.5%SCHEDULE 13G ↗
Jan 29, 2026SCHEDULE 13GACET
Adicet Bio, Inc.
Rupert H. Johnson, Jr.00.0%SCHEDULE 13G ↗
Jan 29, 2026SCHEDULE 13GACET
Adicet Bio, Inc.
Charles B. Johnson00.0%SCHEDULE 13G ↗
Jan 29, 2026SCHEDULE 13GACET
Adicet Bio, Inc.
Franklin Resources, Inc.626,5716.5%SCHEDULE 13G ↗
Oct 10, 2025SCHEDULE 13D/A (amended)ACET
Adicet Bio, Inc.
Orbimed Israel Biofund GP Limited Partnership1.03M0.7%SCHEDULE 13D/A ↗
Oct 10, 2025SCHEDULE 13D/A (amended)ACET
Adicet Bio, Inc.
Orbimed Israel GP Ltd.1.03M0.7%SCHEDULE 13D/A ↗
Oct 10, 2025SCHEDULE 13D/A (amended)ACET
Adicet Bio, Inc.
Orbimed Israel GP II, L.P.646,6570.4%SCHEDULE 13D/A ↗
Oct 10, 2025SCHEDULE 13D/A (amended)ACET
Adicet Bio, Inc.
Orbimed Advisors Israel II Ltd646,6570.4%SCHEDULE 13D/A ↗
Oct 10, 2025SCHEDULE 13D/A (amended)ACET
Adicet Bio, Inc.
OrbiMed Genesis GP LLC1.26M0.8%SCHEDULE 13D/A ↗
Oct 10, 2025SCHEDULE 13D/A (amended)ACET
Adicet Bio, Inc.
Orbimed Capital GP V LLC9.03M5.9%SCHEDULE 13D/A ↗
Oct 10, 2025SCHEDULE 13D/A (amended)ACET
Adicet Bio, Inc.
Orbimed Capital GP VI LLC4.49M2.9%SCHEDULE 13D/A ↗
Oct 10, 2025SCHEDULE 13D/A (amended)ACET
Adicet Bio, Inc.
Orbimed Advisors LLC14.77M9.6%SCHEDULE 13D/A ↗
May 15, 2025SCHEDULE 13G/A (amended)ACET
Adicet Bio, Inc.
Tang Capital Partners IV, Inc00.0%SCHEDULE 13G/A ↗
May 15, 2025SCHEDULE 13G/A (amended)ACET
Adicet Bio, Inc.
Tang Capital Partners III, Inc00.0%SCHEDULE 13G/A ↗
May 15, 2025SCHEDULE 13G/A (amended)ACET
Adicet Bio, Inc.
Tang Capital Partners International, LP3.49M4.2%SCHEDULE 13G/A ↗
May 15, 2025SCHEDULE 13G/A (amended)ACET
Adicet Bio, Inc.
Tang Capital Partners, LP4.73M5.7%SCHEDULE 13G/A ↗

The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 7:12 PM EST.

Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances